Abstracts of the joint meeting of the Pathological Society of Great Britain and Ireland and the Dutch Pathological Society, 186th meeting of the Pathological Society of Great Britain and Ireland. 6-9 July 2004, Amsterdam, The Netherlands.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15366195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment

  2022cites this paper
• A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions.

  2022cites this paper
• Angpt2/Tie2 autostimulatory loop controls tumorigenesis

  2022cites this paper
• Gene expression in the angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study.

  2021cites this paper
• Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies.

  2021cites this paper
• Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial

  2021cites this paper
• Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations

  2020cites this paper
• Tek (Tie2) is not required for cardiovascular development in zebrafish

  2020cites this paper
• Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas

  2020cites this paper
• Plasma and wound fluid levels of eight proangiogenic proteins are elevated after colorectal resection

  2019cites this paper
• Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.

  2019cites this paper
• Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model

  2019cites this paper
• Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease

  2019cites this paper
• Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages

  2018cites this paper
• First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors

  2017cites this paper
• Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions

  2017cites this paper
• Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden

  2017cites this paper
• Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bone Regeneration and Osteosarcoma via Reduction of VEGF and SDF-1

  2017cites this paper
• A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy

  2017cites this paper
• Cortisol-secreting adrenocortical tumours in dogs and their relevance for human medicine.

  2016cites this paper
• Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia

  2016cites this paper
• Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling

  2016cites this paper
• Inhibition of blood vessel formation in tumors by IL‐18‐polarized M1 macrophages

  2016cites this paper
• Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy

  2016cites this paper
• Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds.

  2015cites this paper
• Overexpression of angiopoietin‐2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition

  2015cites this paper
• Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.

  2015cites this paper
• Anti-angiogenic alternatives to VEGF blockade

  2015cites this paper
• Expression of angiogenesis-related genes in canine cortisol-secreting adrenocortical tumors.

  2014cites this paper
• Correlation of MicroRNA-16, MicroRNA-21 and MicroRNA-101 Expression with Cyclooxygenase-2 Expression and Angiogenic Factors in Cirrhotic and Noncirrhotic Human Hepatocellular Carcinoma

  2014cites this paper
• The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor.

  2014cites this paper
• MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.

  2014cites this paper
• Phase II angiogenesis stimulators

  2013cites this paper
• Angiopoietin 2 levels in serum and bronchial lavage fluids and their relationship with cancer stages in lung cancer patients

  2013cites this paper
• Targeting angiopoietin-2 signaling in cancer therapy

  2013cites this paper
• Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2.

  2013cites this paper
• Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.

  2013cites this paper
• Angiopoietins in angiogenesis.

  2013cites this paper
• Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases

  2013cites this paper
• Anthocyanin-Rich Purple Corn Extract Inhibit Diabetes-Associated Glomerular Angiogenesis

  2013cites this paper
• Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer

  2013cites this paper
• Angiogenic Response to Major Lung Resection for Non-Small Cell Lung Cancer with Video-Assisted Thoracic Surgical and Open Access

  2012cites this paper
• Cross‐talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro

  2012cites this paper
• Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617.

  2012cites this paper
• Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.

  2012cites this paper
• Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.

  2012cites this paper
• Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma

  2012cites this paper
• Induction of angiopoietin-2 after spinal cord injury.

  2012cites this paper
• Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases: The Liver as a Permissive Soil

  2012cites this paper
• A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma

  2012cites this paper
• Oral Carnosine Supplementation Prevents Vascular Damage in Experimental Diabetic Retinopathy

  2011cites this paper
• Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

  2011cites this paper
• Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth

  2011cites this paper
• High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

  2011cites this paper
• Angiopoietins 1 and 2 and Tie‐2 receptor expression in human ductal breast disease

  2011cites this paper
• Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML

  2010cites this paper
• A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

  2010cites this paper
• [Angiogenesis in cartilage tumors].

  2010cites this paper
• Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth

  2010cites this paper
• Lymphangiogenesis in cancer: current perspectives.

  2010cites this paper
• Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?

  2010cites this paper
• Angiopoietins.

  2010cites this paper
• Tumor vessel biology in pediatric intracranial ependymoma.

  2010cites this paper
• Antivascular Therapy for Epithelial Ovarian Cancer

  2009cites this paper
• Soluble angiopoietin-2/sTie2 receptor ratio is an independent prognostic marker in adult acute myeloid leukemia

  2009cites this paper
• Angiopoietins contribute to lung development by regulating pulmonary vascular network formation.

  2009cites this paper
• Urinbasierte Angiogenesemarker beim Urothelkarzinom der Harnblase

  2009cites this paper
• Colorectal resection, both open and laparoscopic-assisted, in patients with benign indications is associated with proangiogenic changes in plasma angiopoietin 1 and 2 levels

  2009cites this paper
• Serum Levels of Angiogenic Factors and their Prognostic Relevance in Bladder Cancer

  2009cites this paper
• IP-10 induces dissociation of newly formed blood vessels

  2009cites this paper
• The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme.

  2009cites this paper
• Current and future therapies for age-related macular degeneration

  2009cites this paper
• Angiopoietin-2: Development of inhibitors for cancer therapy

  2009cites this paper
• Colorectal Resection is Associated With Persistent Proangiogenic Plasma Protein Changes: Postoperative Plasma Stimulates In Vitro Endothelial Cell Growth, Migration, and Invasion

  2009cites this paper
• The angiopoietin/Tie2 axis mediates malignant pleural effusion formation.

  2009cites this paper
• Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer.

  2009cites this paper
• Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.

  2009cites this paper
• Reduced Glioma Growth Following Dexamethasone or Anti‐Angiopoietin 2 Treatment

  2008cites this paper
• Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.

  2008cites this paper
• Impact of Angiogenesis Inhibition by Sunitinib on Tumor Distribution of Temozolomide

  2008cites this paper
• Gene array analysis of a rat model of pulmonary arteriovenous malformations after superior cavopulmonary anastomosis.

  2008cites this paper
• Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer

  2008cites this paper
• Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2

  2008cites this paper
• Targeting angiogenesis in pancreatic cancer: rationale and pitfalls

  2008cites this paper
• Low-Energy Electromagnetic Fields Promote Proliferation of Vascular Smooth Muscle Cells

  2008cites this paper
• Differential expression of angiopoietin‐2 and vascular endothelial growth factor in androgen‐independent prostate cancer models

  2008cites this paper
• Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.

  2008cites this paper
• Foxc2 transcription factor: a newly described regulator of angiogenesis.

  2008cites this paper
• The angiogenic factor thymidine phosphorylase up‐regulates the cell adhesion molecule P‐selectin in human vascular endothelial cells and is associated with P‐selectin expression in breast cancers

  2007cites this paper
• Ang‐2 and PDGF‐BB cooperatively stimulate human peripheral blood monocyte fibrinolysis

  2007cites this paper
• Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia

  2007cites this paper
• Angiopoietins in malignancy.

  2007cites this paper
• Potential therapeutic strategies for lymphatic metastasis.

  2007cites this paper
• Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells.

  2007cites this paper
• Angiogenesis in implantation

  2007cites this paper
• Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis

  2007cites this paper
• Fibulin-5 functions as an endogenous angiogenesis inhibitor

  2007cites this paper
• Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer.

  2007cites this paper
• Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.

  2007cites this paper
• Serum angiopoietin-2 as a clinical marker for lung cancer.

  2007cites this paper